SAMSUNG BIOLOGICS earnings per share and revenue

207940 earnings per share for the last quarter are 2521.14 KRW whereas the estimation was 2490.13 KRW which accounts for 1.25% surprise. Företagets omsättning för samma period uppgår till 946.90 B KRW trots den uppskattade siffran 934.23 B KRW. Estimated earnings per share for the next quarter are 3268.30 KRW, and revenue is expected to reach 990.49 B KRW. Also watch annual changes over time to get a bigger picture of 207940 earnings per share and revenue dynamics.